Keywords
Mucous membrane
Oral manifestations
How to Cite
Abstract
This study aims to analyze the oral manifestations affected by COVID-19 through case reports and published studies, in which a possible relationship between COVID-19 and mucocutaneous lesions in the oral cavity and face is presented. The methodology involved a review of the PubMed, Google Scholar, ProQuest, and Medline Complete databases. A total of 26 articles reporting mucocutaneous manifestations in the oral cavity and face associated with COVID-19 were selected. Ninety-one cases with mucocutaneous manifestations in the oral cavity and face associated with COVID-19 were identified. In 18% of the patients, there were facial and oral lesions. Cheeks were the most affected areas (16%), and among oral lesions, the most affected site was the tongue (26%). It is concluded that, according to the findings, the presence of mucocutaneous manifestations in the face and oral cavity is associated with SARS-CoV-2 infection. It is expected that tissues with higher expression of ACE2 and TMPRSS2 are more susceptible to SARS-CoV-2 infection and, consequently, present some type of lesion. Among oral tissues with higher expression of these molecules, the tongue was described, favoring a higher prevalence of lesions.
References
Al‐Khatib A. (2021). Oral manifestations in COVID‐19 patients. Oral diseases, 27(Suppl 3), 779.
Brandão T. B., Gueiros L. A., Melo T. S., Prado-Ribeiro A. C., Nesrallah A. C. F. A., Prado G, V. B. et al. (2021). Lesões orais em pacientes com infecção por SARS-CoV-2: a cavidade oral poderia ser um órgão-alvo? Oral Surg Oral Med Oral Pathol Oral Radiol. 2021;131(2):e45-e51.
Baeder F. M., de Albuquerque A. C. L., Corazza P. F. L., Weigert K. L., Puricelli E., Pasetti L. A., et al. (2021). Oral lesions in patients infected with SARS-CoV-2: a case series. Research, Society and Development, 10(4), e45410414349-e45410414349.
Carreras‐Presas C. M., Sánchez J. A., López‐Sánchez A. F., Jané‐Salas E., Pérez M. L. S. (2021). Oral vesiculobullous lesions associated with SARS‐CoV‐2 infection. Oral diseases, 27(Suppl 3), 710.
Chaux-Bodard A. G., Deneuve S., Desoutter A. (2020). Oral manifestation of Covid-19 as an inaugural symptom?. Journal of Oral Medicine and Oral Surgery, 26(2), 18.
Chen L., Zhao J., Peng J., Li X., Deng X., Geng, Z., et al. (2020). Detection of SARS‐CoV‐2 in saliva and characterization of oral symptoms in COVID‐19 patients. Cell proliferation, 53(12), e12923.
Conti P., Caraffa A., Gallenga C. E., Kritas S. K., Frydas I., Younes A., et al. (2021). The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem. J Biol Regul Homeost Agents, 35(1), 1-4.
de Maria A., Varese P., Dentone C., Barisione E., Bassetti M. (2020). High prevalence of olfactory and taste disorder during SARS‐CoV‐2 infection in outpatients. Journal of medical virology, 92(11), 2310.
dos Santos J. A., Normando A. G. C., da Silva R. L. C., de Paula R. M., Cembranel A. C., Santos-Silva A. R., Guerra E. N. S. (2020). Oral mucosal lesions in a COVID-19 patient: new signs or secondary manifestations?. International Journal of Infectious Diseases, 97, 326-328.
Fantozzi P. J., Pampena E., di Vanna D., Pellegrino E., Corbi D., Mammucari S., et al. (2020). Xerostomia, gustatory and olfactory dysfunctions in patients with COVID-19. American journal of otolaryngology, 41(6), 102721.
Fitzpatrick S. G., Cohen D. M., Clark A. N (2023). Lesões ulceradas da mucosa oral: revisão clínica e histológica. Cabeça Pescoço Pathol. 13(1):91-102.
Gomes S. C., Fachin S., da Fonseca J. G., Angst P. D. M., Lamers M. L., da Silva I. S. B., Nunes, L. N. (2021). Dental biofilm of symptomatic COVID‐19 patients harbours SARS‐CoV‐2. Journal of clinical periodontology, 48(7), 880-885.
Karagounis T. K., Shaw K. S., Caplan A., Sicco K., Femia A. N (2020). Acrofacial purpura and necrotic ulcerations in COVID-19: a case series from New York City. Int J Dermatol. 59(11):1419-1422.
Machhi J., Herskovitz J., Senan A. M., Dutta D., Nath B., Oleynikov M. D., et al. (2020). The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections. Journal of Neuroimmune Pharmacology, 15, 359-386.
Huang N., Pérez P., Kato T., Mikami Y., Okuda K., Gilmore R. C., et al. (2021). SARS-CoV-2 infection of the oral cavity and saliva. Nature medicine, 27(5), 892-903.
Lee R. A., Herigon J. C., Benedetti A., Pollock N. R., Denkinger C. M. (2021). Performance of saliva, oropharyngeal swabs, and nasal swabs for SARS-CoV-2 molecular detection: a systematic review and meta-analysis. Journal of clinical microbiology, 59(5), 1110-1128.
Lloyd-Jones G., Molayem S., Pontes C. C., Chapple I. (2021). The COVID-19 pathway: a proposed oral-vascular-pulmonary route of SARS-CoV-2 infection and the importance of oral healthcare measures. J Oral Med Dent Res, 2(1), 1-25.
Marzano A. V., Cassano N., Genovese G., Moltrasio C., Vena G. A. (2020). Manifestações cutâneas em pacientes com COVID-19: uma revisão preliminar de uma questão emergente. Br J Dermatol. 183(3):431-42.
Mauri A. P., da Silva M. R., do Vale M. C. S., Rios P. A. G. S., Seroli W. (2021). A importancia do cirurgião dentista no ambiente hospitalar para o paciente internado em Unidade de Terapia Intensiva. uma revisão bibliográfica. E-Acadêmica, 2(3), e102342-e102342.
Petrescu N., Lucaciu O., Roman A. (2022). Oral mucosa lesions in COVID‐19. Oral Diseases, 28(Suppl 1), 935.
Riad A., Klugar M., Krsek M. (2022). COVID‐19‐related oral manifestations: early disease features? Oral Diseases, 28(Suppl 1), 940-942.
Rodríguez M. D., Romera A. J., Villarroel M. (2022). Oral manifestations associated with COVID‐19. Oral diseases, 28(Suppl 1), 960.
Sinjari B., D’Ardes D., Santilli M., Rexhepi I., D’Addazi G., Di Carlo, P., et al. (2020). SARS-CoV-2 and oral manifestation: an observational, human study. Journal of clinical medicine, 9(10), 3218.
To K. K. W., Tsang O. T. Y., Yip C. C. Y., Chan K. H., Wu T. C., Chan J. M. C., et al. (2020). Consistent detection of 2019 novel coronavirus in saliva. Clinical Infectious Diseases, 71(15), 841-843.
Wiersinga W. J., Rhodes A., Cheng A. C., Peacock S. J., Prescott H. C. (2020). Pathophysiology, transmission, diagnosis and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. July 10, 2020;324(8):782-793.
Yuki K., Fujiogi M., Koutsogiannaki S. (2020). COVID-19 pathophysiology: A review. Clinical immunology, 215, 108427.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Daniela Firmino dos Santos, Saul Alfredo Antezana-Vera